Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07107568

Assessment of Coronary Artery Disease Before Transcatheter Aortic Valve Replacement: A Randomized, Multicenter, Non-Inferiority Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
700 (estimated)
Sponsor
Medical University Innsbruck · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to determine whether a non-invasive coronary assessment strategy using photon-counting detector computed tomography (PCD-CT) is non-inferior to invasive coronary angiography (ICA) for evaluating coronary artery disease (CAD) prior to transcatheter aortic valve replacement (TAVR) in patients with severe aortic stenosis.

Detailed description

The goal of this randomized, multicenter trial is to assess the safety and efficacy of a non-invasive diagnostic strategy using photon-counting detector computed tomography (PCD-CT) for the assessment of coronary artery disease (CAD) prior to transcatheter aortic valve replacement (TAVR), compared to the current standard of care using invasive coronary angiography (ICA). The trial evaluates the hypothesis that a PCD-CT-guided strategy is non-inferior to routine ICA with respect to the risk of major adverse cardiovascular events (MACE) at 12 months. MACE is defined as a composite of all-cause mortality, nonfatal myocardial infarction, nonfatal stroke, urgent revascularization, or bleeding.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTStandard Invasive Coronary AngiographyStandard invasive coronary angiography performed routinely for all participants in this arm to assess coronary artery disease before TAVR.
DIAGNOSTIC_TESTPCD-CT-Guided Diagnostic StrategyParticipants randomized to this arm will undergo coronary artery disease (CAD) assessment using photon-counting detector computed tomography (PCD-CT). Invasive coronary angiography (ICA) will only be performed if PCD-CT shows significant CAD, defined as ≥70% diameter stenosis in vessels ≥2.5 mm or ≥50% in the left main artery.

Timeline

Start date
2025-08-14
Primary completion
2029-12-31
Completion
2029-12-31
First posted
2025-08-06
Last updated
2025-08-22

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT07107568. Inclusion in this directory is not an endorsement.